Bumper Offer - Urjas oil Just @ Rs. 1
Zyrova Gold 10 Capsule is a prescription drug, available for use as Capsule. It is primarily used for the treatment of High Cholesterol. Secondary and off-label uses of Zyrova Gold 10 Capsule have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Zyrova Gold 10 Capsule. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
While these are the most often observed Zyrova Gold 10 Capsule side effects, there are can be others also. These have been listed below. Normally, these side effects of Zyrova Gold 10 Capsule are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Zyrova Gold 10 Capsule is Severe for pregnant women and Mild for women who are breastfeeding. In addition, Zyrova Gold 10 Capsule's effects on the liver, heart and kidney are discussed below in the Zyrova Gold 10 Capsule related warnings section.
Zyrova Gold 10 Capsule is contraindicated in people with pre-existing medical conditions like Kidney Disease, Hypothyroidism, Drug Allergy as it can result in adverse effects. Other contraindications of Zyrova Gold 10 Capsule have been discussed in the sections ahead.
Additionally, Zyrova Gold 10 Capsule may also adversely react with other medicines. Refer to the list below for further details.
You should also be aware that Zyrova Gold 10 Capsule is safe while driving, and is addiction.
Zyrova Gold 10 Capsule is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Is the use of Zyrova Gold 10 Capsule safe for pregnant women?
Pregnant women may get severe side effects after taking Zyrova. If you are pregnant, do not take Zyrova without a doctor's advice.
Is the use of Zyrova Gold 10 Capsule safe during breastfeeding?
Zyrova has been seen to have minimal side effects on breastfeeding women.
What is the effect of Zyrova Gold 10 Capsule on the Kidneys?
Zyrova can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Zyrova Gold 10 Capsule on the Liver?
You may experience side effects on your liver after taking Zyrova. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Zyrova Gold 10 Capsule on the Heart?
Zyrova is rarely harmful for the heart.
Zyrova Gold 10 Capsule should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Zyrova Gold 10 Capsule unless your doctor advises you to do so -
Is this Zyrova Gold 10 Capsule habit forming or addictive?
No, there is no any evidence that Zyrova Gold 10 Capsule is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Zyrova Gold 10 Capsule does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Yes, but consume Zyrova Gold 10 Capsule only on doctor's advice.
Is it able to treat mental disorders?
Zyrova Gold 10 Capsule is unable to treat or cure mental disorders.
Interaction between Food and Zyrova Gold 10 Capsule
Some foods when eaten with Zyrova Gold 10 Capsule can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Zyrova Gold 10 Capsule
Consuming Zyrova Gold 10 Capsule with alcohol can have many serious effects on your body.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Durlaza (aspirin)
KD Tripathi. Essentials of Medical Pharmacology. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 195-199
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 191-194
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Durlaza (aspirin)
KD Tripathi. Essentials of Medical Pharmacology. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 195-199
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 191-194
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Plavix (clopidogrel bisulfate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 630-631
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 335-336
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Durlaza (aspirin)
KD Tripathi. Essentials of Medical Pharmacology. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 195-199
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 191-194
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Plavix (clopidogrel bisulfate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 630-631
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 335-336
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650